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Abstract
Background: The Health and Health Services Research Fund (HHSRF) is dedicated to support
research related to all aspects of health and health services in Hong Kong. We evaluated the fund's
outcomes and explored factors associated with the translation of research findings to changes in
health policy and provider behaviour.
Methods: A locally suitable questionnaire was developed based on the "payback" evaluation
framework and was sent to principal investigators of the completed research projects supported
by the fund since 1993. Research "payback" in six outcome areas was surveyed, namely knowledge
production, use of research in the research system, use of research project findings in health
system policy/decision making, application of the research findings through changed behaviour,
factors influencing the utilization of research, and health/health service/economic benefits.
Results: Principal investigators of 178 of 205 (87%) completed research projects returned the
questionnaire. Investigators reported research publications in 86.5% (mean = 5.4 publications per
project), career advancement 34.3%, acquisition of higher qualifications 38.2%, use of results in
policy making 35.4%, changed behaviour in light of findings 49.4%, evidence of health service benefit
42.1% and generated subsequent research in 44.9% of the projects. Payback outcomes were
positively associated with the amount of funding awarded. Multivariate analysis found participation
of investigators in policy committees and liaison with potential users were significantly associated
with reported health service benefit (odds ratio [OR]participation = 2.86, 95% confidence interval [CI]
1.28–6.40; ORliaison = 2.03, 95% CI 1.05–3.91), policy and decision-making (ORparticipation = 10.53,
95% CI 4.13–26.81; ORliaison = 2.52, 95% CI 1.20–5.28), and change in behavior (ORparticipation = 3.67,
95% CI 1.53–8.81).
Conclusion: The HHSRF has produced substantial outcomes and compared favourably with
similar health research funds in other developed economies. Further studies are needed to better
understand the factors and pathways associated with the translation of research findings into
practice.
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While research is believed to be essential in guiding
improvements in health systems and developing new ini-
tiatives [1], there is growing recognition of the importance
of measuring its returns [2-7]. In developed countries with
long histories of publicly financing health research, pro-
viding evidence of benefit has increasingly become the cri-
terion by which research agencies are evaluated and
funding continuation assessed [8,9]. Evaluating research
outcomes potentially allows the development of more
effective strategies to increase the likelihood of the imple-
mentation of "successful" research [7].
Although the "best" way to evaluate research outcomes
remains controversial, there is a general consensus that
the evaluation should capture not only "academic" out-
puts (e.g. peer reviewed papers), but wider attributable
health and socio-economic benefits that may include
knowledge production, research targeting and capacity
building, informing policy/decision making, behaviour
change, product development, health and health service
benefits and economic benefits [3-6,10]. Aiming to
encompass these multiple dimensions, the "payback"
framework, developed in the 1990s, is gaining popularity
to become one of the most widely adopted models to
evaluate health research funds internationally (Table 1)
[11-17].
Although Hong Kong currently enjoys a relatively affluent
economy, public funding for academic research was only
formally established in the late 1980s. Funding allocation
for projects in the fields of biology and medicine typically
accounts for approximately one third of the total research
budget [18]. Recognizing the need for locally relevant evi-
dence to inform health policy and practice, the govern-
ment has been supporting applied health research
through the Health and Health Services Research Fund
(HHSRF) since 1993. The fund aims to maximize popula-
tion health, improve the quality of life, and enhance the
standard and cost-effectiveness of the health system
through funding research that generates new knowledge
in areas of human health and health services [19].
To demonstrate accountability of public funding and to
provide an evidence base for assessment of continuation
of funding, we undertook for the first time a systematic
evaluation of outcomes of research projects supported by
the fund since it was established in 1993. The objectives
of the study were to quantify the outcomes of completed
research projects supported by the fund using the "pay-
back" framework, in comparison with the more estab-
lished health research funds abroad. We also explored
factors associated with the impact of research outcomes
on health policy and provider behaviour. Our results
could have relevance for research funds planning similar
evaluation exercises, particularly those that are less well
established.
Methods
Research projects evaluated
The HHSRF awards competitive grants to support a
diverse range of health research projects, with an empha-
sis on public health and health services. Application to the
fund is open to all professionals engaged in health
research in Hong Kong, including those in academic insti-
tutions, public and private healthcare sectors. Applica-
tions are subject to a stringent peer review process by both
international and local experts. Each finished project is
required to submit a final report. When the final report is
considered satisfactory after peer review, the project is
considered "completed". As of March 2006, out of 1,346
applications received, a total of 285 projects worth
HKD110.1 million (HKD 7.8 = USD 1) have been
approved for funding. Of these, 205 projects worth HKD
73.1 million (HKD 7.8 = USD 1) have been completed
and were the subject of this study (Figure 1). The mean
funding amount per completed project was HKD356,585
(median HKD341,048, range HKD 6,110 to HKD
993,300). The usual funding ceiling per project was HKD
800,000 and the standard maximum duration was 24
months.
Development of evaluation questionnaire
We adapted the payback evaluation framework question-
naire developed by the Health Economics Research Group
Table 1: Categories of outcome in the "payback" framework
1) Knowledge production: any accepted peer or non-peer reviewed publication (journal article, abstract, editorial, letter, book, book chapter, 
conference proceeding, report or others).
2) Use of research in the research system: a) the acquisition of formal qualifications by members of the research team, other research staff or 
prostgraduate students, b) career advancement for any members of the project team, and c) use of project findings for methodology in subsequent 
research by members of the project team
3) Use of research project findings in health system policy/decision making: project findings that could be used in policy/decision making at any level 
of the health service such as geographic level and organisation level
4) Application of the research findings through changed behaviour: changes in behaviour observed or expected through the application of findings 
to research-informed policies at a geographical, organisation and population level
5) Factors influencing the utilisation of research: estimated impact of research dissemination in terms of policy/decision making/behavioural change.
6) Health/health service/economic benefits arising from funded research: benefits that may or are expected to accrue from research funding such as 
improved service delivery; cost savings; improved health; or increased equity.Page 2 of 10
(page number not for citation purposes)
BMC Health Services Research 2007, 7:121 http://www.biomedcentral.com/1472-6963/7/121at Brunel University, UK [14]. The revised questionnaire
contained additional items drawn from literature review
and consultation with local experts. A pilot test was con-
ducted on 5 projects to assess the acceptability and feasi-
bility of the questionnaire in the local setting. Minor
modifications were made to better reflect the local context
and readability. The final questionnaire [See Additional
File 1] comprised six sections: a) knowledge production,
b) use of research in the research system, c) use of research
project findings in health system policy/decision making,
d) application of the research findings through changed
behaviour [12], e) factors influencing the utilization of
research, and f) health/health service/economic benefits.
Data collection
We sent the questionnaire in March 2006 to the principal
investigators (PI) of the 205 completed projects (i.e. one
questionnaire per project). To maximize return, at two to
four week time intervals, we sent reminders to PIs via
email, fax and/or by telephone. Where the PIs had left
Hong Kong, co-investigators were invited to complete the
questionnaire. The deadline for returning the completed
questionnaires was end of June 2006. Returned question-
naires were checked for missing, inconsistent or unclear
responses. Where necessary, PIs were contacted for further
clarification.
Data processing
We counted the total number of publications reported for
each project by the PIs in the returned questionnaires and
categorized publications into those published in peer
reviewed or non-peer reviewed journals for analysis. For
publications indexed by the Science Citation Index or
Social Sciences Citation Index of the Institute of Scientific
Information (ISI) [20,21], we retrieved the number of
citations per publication as of July 2006, and the impact
factor and rank within its subject category of the journal
in which the publication appeared from the ISI website as
of 2004. Based on the information provided by the PIs in
the returned questionnaires, we counted the number of
academic qualifications or career promotions acquired by
members of the research team, the policies influenced,
and behaviours changed or influenced for each project.
Except for knowledge production, PIs were asked to esti-
mate the contribution or expected impact of the research
project on a categorical scale (considerable [≥ 75%], mod-
erate [26–74%] or small [≤ 25%]). PIs were also asked to
give evidence to support their impact assessment and par-
ticipation in health-related policy/advisory committees.
In addition, PIs were asked in the questionnaire whether
there was any liaison with potential users of the research
findings prior to or during the conduct of the project and
the reply was counted as a dichotomous response.
We retrieved the investigator and project demographics,
including type of project administering institution (uni-
versity, hospital, or other agency), department or work
place affiliation of the PIs, funding award in Hong Kong
dollars and project duration, from the fund's electronic
management database. Funding awards and project dura-
tion were categorized into tertiles respectively: low (HKD
6,110 – HKD 97,180), medium (HKD 98,940 – HKD
529,900), and high (HKD 532,242 – HKD 993,300); and
short (4 – 15 months), intermediate (>15 – 24 months),
and long (>24 – 56 months). To explore the impact of
time on research publication we computed the duration
from project completion in years dichotomizing the vari-
able at the mean for the analysis.
Statistical analysis
Univariate analyses by Chi-square test and Student t-test
were used to test associations or differences between
projects with and without returned questionnaires, and
between the payback framework categories and funding
award. We used logistic regression to identify factors asso-
ciated with the uptake of research to inform policy deci-
sions, leading to behavioural change or health service
benefit adjusting for the number of peer reviewed publi-
cations, post-completion participation of the PI in heath-
related policy/advisory committees, pre- or post-liaison
with potential users, funding amount, project duration
and type of administering institution. We used negative
binomial regression, accounting for over dispersion in the
data, to examine the association between the mean
number of peer-reviewed publications and the fund
Flow diagram of projects funded by the Health and Health Services Research Fund (HHSRF) from 1993 to March 2006igur  1
Flow diagram of projects funded by the Health and Health 
Services Research Fund (HHSRF) from 1993 to March 2006.
1,346 submitted 
proposals
285 projects approved for funding
10 projects withdrawn: 
?? 4 by project investigators
?? 6 by HHSRF  
32 projects ongoing 243 projects finished 
38 projects with final 
reports under review 
205 projects “completed” 
with satisfactory final reportsPage 3 of 10
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and the type of project administering institution.
We analyzed the data using SAS for Windows (version
9.1). P-values of <0.05 (two-sided) were considered statis-
tically significant.
Results
Of the 205 questionnaires sent, 178 (86.8%) were com-
pleted and returned by investigators. The mean duration
between project completion and questionnaire return was
6.34 years (median 6.25, range 1.75 to 10.92), which was
significantly shorter than that for projects for which ques-
tionnaires were not returned (mean 7.76 years, median
7.75, range 3.25 to 10.83). The questionnaire response
rate was inversely related to the time from project comple-
tion (p <0.001, R2 = 0.75; Figure 2). In particular, signifi-
cantly greater proportion of questionnaires were returned
for projects completed 7 years or less compared with those
completed longer than 7 years (94.0% [109/116] vs.
77.5% [69/89], odds ratio [OR] 4.51, 95% confidence
interval [CI] 1.81–11.23).
Otherwise, there was no significant difference between
projects for which questionnaires were returned and not
returned in terms of the funding award, duration of
project, or the type of administering institution (Table 2).
Research payback
Knowledge production
Among the 178 projects with returned questionnaires,
154 (86.5%) reported research publications. The mean
number of publications per project was 5.4 (standard
deviation [SD] 8.1). 70.8% (126 of 178) of projects
reported peer reviewed publications with a mean number
of 2.1 (SD 2.7) per project. Among the 377 peer-reviewed
publications, 295 (78.2%) were published in journals
that were listed in ISI Science or Social Sciences Citation
Index. These publications had a mean of 1.9 (SD 4.0) cita-
tions per year (Table 3). 18.6% of the peer reviewed pub-
lications were published in one of the top three journals
of their respective subject categories or in journals with
impact factors greater than 7. The average expenditure per
peer-reviewed publication was HKD 167,690.
Research targeting and capacity building
Career advancement of research team members was
reported for 34.3% (61 of 178) of projects (median 1
project team member per project, range 1 to 4); of these,
the impact by the projects on this outcome was consider-
able (≥ 75%) in 13.2%. Acquisition of higher qualifica-
tions was reported for 38.2% of projects (68 of 178,
median 1 postgraduate degree per project, range 1 to 6);
of these, the impact by the projects was considerable in
57.3%. As an indication of research capacity building,
44.9% (80 of 178) of projects led to subsequent research
(median 1 new research project per project, range 1 to 7);
of these, the impact by the projects was considerable in
37.4%. In total, there were 115 new research projects
worth HKD 123.0 million.
Informing policy, behaviour change, health service benefits
About one third (35.4%) of the projects reported impact
on informing policy through treatment guidelines, treat-
ment protocols, reference standards, and Cochrane
reviews; many led to participation of PIs in health-related
policy/advisory committees. An example was the inclu-
sion of results from funded projects in formulation of
guidelines on the use of non-steriodal anti-inflammatory
drugs and COX-2 inhibitors by the 2005 US Task Force
and the Maastricht-3 Consensus Report.22 As another
notable example, funding for the prevalence and eco-
nomic impact of tobacco induced diseases, and effective-
ness of smoking cessation has provided pivotal support
for changes to tobacco legislation and regulation [23].
About one half (49.4%) of the projects were reported to
have led to changes in behaviour or clinical practice in
health service managers, providers and the general public.
The PIs of 42.1% of the projects reported health service
benefit from the funded projects including cost reduction
through the adoption of cost effective treatment strategies,
qualitative improvements in health service delivery,
improve effectiveness of public health policies, and reve-
nue gained from the selling of intellectual property rights.
For instance, in addition to providing evidence to support
legislation changes, results from the tobacco related stud-
ies have influenced the uptake of smoking cessation inter-
Questionnaire return rate by years from project completionFigure 2
Questionnaire return rate by years from project completion.
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Table 3: Association between funding award and research payback
Funding Award*
Low Moderate High P value
N (%) n(%)
Knowledge production
Projects with publications 154(86.5) 45 (79.0) 56 (87.5) 53(93.0) 0.09
Mean(SD) Mean (SD)
Publications per project 5.4 (8.1) 2.8 (3.2) 5.0(5.6) 8.5(12.0) <0.001
Peer reviewed publications per project 2.1(2.7) 1.1(1.7) 2.0(2.5) 3.3(3.3) <0.001
Journal impact factor 3.0(3.9) 1.9(1.6) 2.7(2.7) 3.5(5.0) <0.001
Journal ranking 19.7(24.7) 35.7(45.7) 17.0(16.7) 16.1(15.2) 0.02
Citations per year 1.9(4.0) 2.5(6.4) 1.3(1.4) 2.2(4.1) 0.23
N (%) n(%)
Research utilisation
Led to participation in health-related policy/advisory committees post research 
completion
34(19.1) 8(14.0) 13(20.3) 13(22.8) 0.47
Pre- and during- research process liaison with potential users 69(38.8) 19(33.3) 25(39.1) 25(43.9) 0.51
Research targeting and capacity building
Generated subsequent research 80(44.9) 16(28.1) 29(45.3) 35(61.4) 0.002
Led to qualifications 68(38.2) 19(33.3) 20(31.3) 29(50.9) 0.06
Led to career advancement 61(34.3) 9(15.8) 25(39.1) 27(47.4) 0.001
Informing policy and decision making
Findings used in policy making 63(35.4) 13(22.8) 23(35.9) 27(47.4) 0.02
Findings expected to be used in policy making 32(27.8) 5(11.4) 14(34.2) 13(43.3) 0.01
Application of the findings through changed behaviour
Led to changes in behaviour 88(49.4) 23(40.4) 27(42.2) 38(66.7) 0.01
Expected to lead to changes in behaviour 36(40.0) 10(29.4) 16(43.2) 10(52.6) 0.22
Health and health service benefit
Reported health service benefit 75(42.1) 23(40.4) 24(37.5) 28(49.1) 0.41
Expected future health service benefit 34(33.0) 8(23.5) 11(27.5) 15(51.7) 0.04
*Low = HKD 6,110–97,180; Moderate = HKD98,940–529,900; High = HKD532,242–993,300.
Table 2: Comparison of characteristics of projects with evaluation questionnaire returned or not returned
Projects with questionnaires returned Projects without questionnaires returned
N % N % P value
Administering institutions
Universities 152 86.9% 23 13.1% 1.000
Hospitals and other agencies 26 86.7% 4 13.3%
Mean SD Mean SD p-value
Years from project completion 6.34 2.27 7.76 1.79 <0.001
Funding award (HKD) 355,163 275,492 367,338 275,381 0.832
Project duration (months) 20.6 10.1 20.1 8.6 0.770
BMC Health Services Research 2007, 7:121 http://www.biomedcentral.com/1472-6963/7/121ventions by the public hospital authority and Department
of Health in Hong Kong [23]. Univariate analyses revealed
a significant funding dose response gradient (higher fund-
ing awards) with almost all aspects of the payback catego-
ries (Table 3).
Comparison with other research funds
Based on the modified payback framework we bench-
marked the outputs and outcomes of HHSRF funded
research against those reported by funds of other coun-
tries. Two National Health Service Research and Develop-
ment Programmes in the UK [12,13] were selected for
comparison. Although these evaluations focused on spe-
cific research programmes rather than an overall pro-
gramme they were of similar funding scope to the HHSRF
and also evaluated by the payback framework. There is a
striking similarity between these three evaluations and the
HHSRF compared favorably in all payback categories (Fig-
ure 3).
Factors associated with the impact of research outcomes 
on health policy and provider behaviour
Table 4 shows that participation in health related policy/
advisory committees post research completion and liai-
son with potential users pre- and during-the research
process were independently predictive of reported health
and health service benefit (ORparticipation = 2.86, 95% CI
1.28–6.40; ORliaison = 2.03, 95% CI 1.05–3.91), policy
and decision-making (ORparticipation = 10.53, 95% CI 4.13–
26.81; ORliaison = 2.52, 95% CI 1.20–5.28), and applica-
tion of the findings through behaviour change (ORparticipa-
tion = 3.67, 95% CI 1.53–8.81). Increased funding award
was also associated with increased behaviour change
(ORhigh = 3.01, 95% CI 1.05–8.66).
Results from negative binomial regression analysis
showed that significantly greater number of peer-reviewed
papers published was found for projects with high (HKD
532,242 – HKD 993,300) funding awards (mean differ-
ence 0.76 compared with projects with low funding
awards, 95% CI 0.19–1.33). Although projects with inter-
mediate duration (15 – 24 months) appeared to have
greater number of peer-reviewed publications compared
to those with short duration (4 – 15 months), project
duration was not significantly associated with such publi-
cations overall (Table 5).
The effect of post research participation in health related
policy/advisory committees and pre- or during-liaison
with potential users is an essential component of the
translation of research into practice, this effect is most
likely strongest at the local level. Publication is necessary
for international impact. The principal investigators
reported numerous examples of research related impact
ranging from the evaluation of unit based protocols and
service delivery at the local departmental/hospital level;
the development guidelines, programme planning and
initiation applicable across Hong Kong; and inclusion of
research outcomes in international treatment guidelines
and protocols through the Cochrane library and WHO at
the international level. Some examples are given in Table
6.
Discussion
Research is recognized as an essential feature of health
care development and is increasingly used to influence all
levels of health care provision. However, in most health
care systems, including that in Hong Kong, the assessment
of need, delivery of care and evaluation of preventive
health and medical interventions has not been a strong
feature. Health services research has the potential to sub-
stantially contribute to and influence health-related deci-
sion-making whether at the policy, practice, individual
patient or population level. Well-structured research pro-
grammes are fundamental to adequate monitoring of the
massive investments governments make in health care
and to ensuring the appropriateness of future health care
provision. Pressure to assess "value for money" in the use
of public sector resources for research funding has risen in
recent years [2-9]. Documenting the attributable research
funding outputs or outcomes is essential for establishing
the evidence base substantiating the "payback" or return
on investment of public funds made available for health
care research.
Comparison of the Health and Health   Services Research Fund (HHSRF) and two National Health Serviceand  Development Pr grammes (NHS-1 [12] and NHS-2 [13]) in vari us payback   c tegoriesigure 3
Comparison of the Health and Health   Services Research 
Fund (HHSRF) and two National Health Service Research 
and   Development Programmes (NHS-1 [12] and NHS-2 
[13]) in various payback   categories.
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comes from a single public health research fund using the
payback framework in terms of the number of individual
projects evaluated. The robustness of findings of the
present study has benefited from the high rate of return of
evaluation questionnaires by the investigators (86.8%),
reducing the risk of bias. Indeed among projects com-
pleted within the past 7 years, questionnaires were
returned for nearly 95% of projects. The rate of question-
naire return dropped off significantly for projects com-
pleted more than 7 years before, which might reflect a
lower incentive for investigators to respond due to the
Table 5: Factors associated with the publication of peer reviewed journal papers
Mean Difference (95% CI) P value
Funding award 0.02
Low 0
Moderate 0.32 (-0.19,0.83)
High 0.76 (0.19,1.33)
Project duration (months) 0.12
Short (4 – 15 months) 0
Intermediate (15 – 24 months) 0.53 (0.01,1.04)
Long (24 – 56 months) 0.49 (-0.05,1.04)
Years from project completion 0.43
≤ 7 years 0
> 7 years 0.16 (-0.23, 0.54)
Administering institution 0.51
Universities 0.19 (-0.36, 0.73)
Hospitals and other agencies 0
*Low = HKD 6,110 – 97,180; Moderate = HKD98,940 – 529,900; High = HKD532,242 – 993,300.
CI, confidence interval
Table 4: Factors associated with the uptake of research to inform policy decisions, lead to behavioural change and health service 
benefit
Informing policy and
decision making
Application of the findings
through changed behaviour
Health and health
service benefit
Adjusted Odds
Ratio (95% CI)
P value Adjusted Odds
Ratio (95% CI)
P value Adjusted Odds
Ratio (95% CI)
P value
Knowledge production 0.79 0.88 0.08
No peer reviewed publications 1.00 1.00 1.00
≤ 2.1 publications per project 0.80(0.32, 2.00) 1.22(0.54, 2.75) 2.38(1.05, 5.40)
>2.1 publications per project 0.70(0.25, 1.96) 1.20(0.48, 2.98) 1.27(0.50, 3.21)
Research utilisation
Participation in health-related policy/advisory 
committees post research completion
10.53(4.13, 26.81) <0.001 2.86(1.28, 6.40) 0.01 3.67(1.53, 8.81) 0.004
Pre- and during- research process liaison with potential 
users
2.52(1.20, 5.28) 0.01 2.03(1.05, 3.91) 0.03 1.09(0.56, 2.15) 0.79
Funding award* 0.17 0.56 0.04
Low 1.00 1.00 1.00
Moderate 1.98(0.72, 5.39) 0.85(0.36, 1.99) 1.03(0.44, 2.42)
High 3.18(0.95, 10.71) 1.34(0.47, 3.78) 3.01(1.05, 8.66)
Project duration (months) 0.72 0.97 0.24
Short (4 – 15 months) 1.00 1.00 1.00
Intermediate (15 – 24 months) 0.74(0.26, 2.12) 0.93(0.37, 2.31) 0.51(0.20, 1.29)
Long (24 – 56 months) 1.04(0.34, 3.22) 1.01(0.37, 2.76) 0.90(0.33, 2.46)
Administering institution 0.87 0.26 0.71
Universities 1.10(0.36, 3.33) 0.58(0.23, 1.48) 1.20(0.45, 3.18)
Hospitals and other agencies 1.00 1.00 1.00
*Low = HKD 6,110–97,180; Moderate = HKD98,940–529,900; High = HKD532,242–993,300
CI, confidence intervalPage 7 of 10
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observation might have implication for the optimal tim-
ing to conduct studies of similar nature in future.
In spite of the fact that the total amount of funding
awarded to the projects evaluated in this study is only a
fraction of that awarded by more established research
funds in other countries (for instance, the UK Medical
Research Council's total research spending was GBP3.76
billion between 1995 and 2005) [24], our study docu-
mented a significant contribution of the HHSRF to knowl-
edge generation through scientific publication at a level
comparable to overseas research funds of a similar nature.
This is demonstrated both in terms of the number of pub-
lications per funded project (HHSRF: mean 5.4 vs. Aus-
tralian NHMRC [9]: mean 4.3) and 'value for money' in
terms of expenditure per peer reviewed publication
(HHSRF: mean HKD 167,690 vs. Australian NHMRC [9]:
AUD 37,400 [approximately HKD 228,257]). However, it
should be pointed out that these figures do not reflect the
true total expenditure per publication, as the amount con-
tributed by other funding sources, including those sup-
porting the salaries of senior investigators, is unknown.
Although a number of publications were in high impact
journals we were unable to explicitly assess their individ-
ual impact on knowledge transfer of research into prac-
tice.
We found relatively fewer subsequent research projects
(44.9%) generated by HHSRF-funded projects. This might
reflect the relatively lack of funding opportunities for
investigators in Hong Kong – it is estimated that only
0.69% of Hong Kong's gross domestic product (GDP) was
spent on research and development in all disciplines of
science and technology in 2004, while the corresponding
figures were 2.78% in the UK, 2.67% in USA, 1.96% in
Canada, and 1.69% in Australia [25]. Nonetheless, the
HHSRF has been instrumental in supporting the develop-
ment of research capacity and building a research culture
in Hong Kong. In addition, HHSRF-funded projects have
led to similar outcomes in terms of change in policy and
self-perceived health service benefit compared with over-
seas funds evaluated by the same payback framework (Fig-
ure 3).
With the relatively large sample of projects evaluated, we
were able to explore factors associated with research out-
comes. It is perhaps not surprising to find that increased
funding awards were significantly associated with greater
outcomes in a range of payback categories. Perhaps more
importantly, by multivariate analysis, we found that liai-
son with policy makers and integration of researchers in
the policy formulation process, rather than publications
or funding award, were the key factors influencing health
behaviour change, health policy and health care benefit,
confirming previous impressions [26,27].
The intrinsic limitations of the payback framework and
the way it was applied should be recognized. Since infor-
mation on project outcomes was provided by the investi-
gators retrospectively, responses may reflect 1) recall bias,
2) over or under estimation of the effect of the research
outcomes and 3) measurement error as the specific impact
of the effect could not be explicitly measured and verified
in all cases. There is inevitably a degree of subjectivity
when researchers attribute their research findings to
changes in health policy and behaviour, which involve a
complex process with multiple factors at play, including
political and economic consideration. It is also well recog-
nized that researchers in different traditions or cultures
vary in the way they conceptualize and explain the impact
of their research [28]. It is likely that the heterogeneity in
characteristics of the investigators sampled in this study
has diluted the effect of the outcomes. In addition,
Table 6: Examples of impact of research outcomes on health policy and provider behaviour
Local hospital/health service level
 Improved reporting of unintentional child injury cases and liaison between the Hospital Authority Informatics and Accident and Emergency 
departments
 Improved liaison between the Education and Manpower Bureau and the Hospital Authority Child Psychiatry Services to address identification 
and treatment for children/adolescents at risk of suicide
Hong Kong-wide level
 Improved protocols and pathways for monitoring treatment progress and readiness for discharge from hospitals
 Development of a programme protocol for the Pneumoconiosis Compensation Fund Board
 Translation and validation of more than 17 internationally recognized questionnaires and scales into Chinese
 Provided scientific evidence to support the Hong Kong Tobacco Control Legislation
International level
 Research outcomes used in the support of Helicobacter pylori management guidelines (Maastricht-2 and Maastricht-3 Consensus Reports)
 Research outcomes guided Occupational Health Surveillance programmes in China and were influential in the inclusion of smoking as a health 
hazard for workers in China
 Inclusion in the Cochrane meta-analysis for the Cochrane Tobacco Addiction Review Group and Injury Prevention for RunnersPage 8 of 10
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detailed questionnaire might also lead to response and
information bias. In our study, the overall impact might
also be underestimated, as PIs of projects completed more
than 7 years prior to the survey were less likely to respond.
Nonetheless, despite these shortcomings, with its growing
acceptance by researchers and funding agencies, the pay-
back framework represents a useful common tool by
which the multiple dimensions of health research out-
comes can be quantitatively and qualitatively measured,
facilitating comparison in evaluation across different
funds.
Conclusion
In conclusion, despite the relatively young age and mod-
est budget of the fund, the HHSRF has resulted in substan-
tial outcomes as measured by a multi-level payback
framework. As expenditure on research activities has to
compete with alternative uses of scarce health services
resources, the benefits arising from the investment should
withstand rigorous evaluation. Quantifying the impact
and payback of health services research and demonstrat-
ing the societal benefits is essential to providing the plat-
form for continued policy support for health services
research funding. Future research should focus on the
overall long-term societal benefit factors that influence
the uptake and translation of research into practice, and
on improving the match between investigator initiated
and policy directed research.
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